M10.28
Drug-induced gout, vertebrae
Clinical Classification Guidelines
Medical Intelligence & Overview
Drug-induced gout of the vertebrae, classified under ICD-10 code M10.28, is a form of gout that occurs when certain medications cause uric acid buildup in the spinal bones. Gout typically affects joints in the extremities, such as the toes and ankles, but in this rare form, it targets the vertebrae—the bones making up the spine. This condition can lead to pain, inflammation, and potential complications if not properly managed. Recognizing the impact of medications on uric acid levels is essential for preventing and managing this condition.
Causes & Symptoms
Clinical Causes: Use of medications that increase uric acid levels, such as diuretics (e.g., hydrochlorothiazide). Chemotherapy drugs that can alter purine metabolism. Medications prescribed for other conditions that have side effects increasing uric acid, like aspirin at certain doses. Chronic use of drugs associated with impaired renal function, leading to decreased uric acid excretion.
Key Symptoms: Localized back pain, often severe and persistent. Swelling and redness around affected vertebrae. Limited spinal mobility, making movement difficult or painful. Potential nerve compression symptoms such as numbness or weakness if swelling affects surrounding nerves. Fever and general discomfort in advanced cases.
Diagnostic & Treatment
Diagnosis Path: Diagnosing drug-induced gout of the vertebrae involves a combination of medical history, especially medication use, and imaging studies. The process may include:
Treatment Protocols: Managing drug-induced gout of the vertebrae involves a multifaceted approach aimed at symptom relief and addressing underlying causes:
Clinical Advice & FAQs
Billing Guidance
Is M10.28 a billable ICD-10 code?
Yes, M10.28 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.28?
Clinical documentation must specify the nature of Drug-induced gout, vertebrae and any associated comorbidities for accurate reporting.
Cite this Clinical Reference